- Home
- THRD vs POET Comparison
THRD vs POET Comparison
Compare THRD & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- POET
- Stock Information
- Founded
- THRD 2019
- POET 1972
- Country
- THRD United States
- POET Canada
- Employees
- THRD N/A
- POET N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- THRD Health Care
- POET Technology
- Exchange
- THRD Nasdaq
- POET Nasdaq
- Market Cap
- THRD 335.2M
- POET 278.3M
- IPO Year
- THRD 2022
- POET N/A
- Fundamental
- Price
- THRD $6.00
- POET $5.49
- Analyst Decision
- THRD Strong Buy
- POET Strong Buy
- Analyst Count
- THRD 3
- POET 2
- Target Price
- THRD $20.33
- POET $6.25
- AVG Volume (30 Days)
- THRD 248.2K
- POET 3.3M
- Earning Date
- THRD 11-07-2024
- POET 03-14-2025
- Dividend Yield
- THRD N/A
- POET N/A
- EPS Growth
- THRD N/A
- POET N/A
- EPS
- THRD N/A
- POET N/A
- Revenue
- THRD N/A
- POET $119,946.00
- Revenue This Year
- THRD N/A
- POET N/A
- Revenue Next Year
- THRD N/A
- POET $9,744.96
- P/E Ratio
- THRD N/A
- POET N/A
- Revenue Growth
- THRD N/A
- POET N/A
- 52 Week Low
- THRD $5.60
- POET $1.00
- 52 Week High
- THRD $16.94
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- THRD 23.75
- POET 52.31
- Support Level
- THRD $5.60
- POET $4.80
- Resistance Level
- THRD $11.78
- POET $5.22
- Average True Range (ATR)
- THRD 0.89
- POET 0.51
- MACD
- THRD -0.43
- POET -0.13
- Stochastic Oscillator
- THRD 6.50
- POET 40.78
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.